Canonical and non-canonical functions of the non-coding RNA component (TERC) of telomerase complex
- PMID: 40025596
- PMCID: PMC11871756
- DOI: 10.1186/s13578-025-01367-0
Canonical and non-canonical functions of the non-coding RNA component (TERC) of telomerase complex
Abstract
The telomerase complex consists of a protein component (TERT), which has reverse transcriptase activity, and an RNA component (TERC), which serves as a template for telomere synthesis. Evidence is rapidly accumulating regarding the non-canonical functions of these components in both normal or diseased cells. An oligonucleotide-based drug, the first telomerase inhibitor, secured FDA approval in June 2024. We recently summarized the non-canonical functions of TERT in viral infections and cancer. In this review, we expand on these non-canonical functions of TERC beyond telomere maintenance. Specifically, we explore TERC's roles in cellular aging and senescence, immune regulation, genetic diseases, human cancer, as well as involvement in viral infections and host interactions. Finally, we discuss a transcription product of telomere repeats, TERRA, and explore strategies for targeting TERC as a therapeutic approach.
Keywords: Non-canonical functions; Non-coding RNAs; TERC; TERT; Telomerase; Telomeres.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors have nothing to report.
Figures
References
Publication types
Grants and funding
- R01 CA276474/CA/NCI NIH HHS/United States
- R01CA222148/Division of Cancer Epidemiology and Genetics, National Cancer Institute
- U01 CA278927/CA/NCI NIH HHS/United States
- R33CA258016/Division of Cancer Epidemiology and Genetics, National Cancer Institute
- U01CA278927/Division of Cancer Prevention, National Cancer Institute
LinkOut - more resources
Full Text Sources
